From: A systematic review of penile prosthesis infection and meta-analysis of diabetes mellitus role
Study | Year | Design | Level of evidence grade | Period | Prosthesis type | Patient n | Infection n | Infectionrate (%) | |
---|---|---|---|---|---|---|---|---|---|
1 | Carson et al. [34] | 1983 | Prospective | Low quality | 1979–1982 | Inflatable | 100 | 1 | 1.00 |
2 | Furlow et al. [35] | 1987 | Prospective | Low quality | 1985–1987 | Inflatable | 120 | 1 | 0.83 |
3 | Kabalin and Kessler [36] | 1988 | Prospective | Low quality | 1975–1985 | Scott reoperation | 153 | 4 | 2.61 |
Scott naive | 264 | 5 | 1.89 | ||||||
4 | Cumming and Pryor [37] | 1991 | Prospective | Low quality | 1983–1987 | Inflatable and malleable | 280 | 32 | 11.43 |
5 | Radomski and Herschorn [38] | 1992 | Prospective | Low quality | 1979–1989 | Inflatable and semi-rigid | 269 | 6 | 2.23 |
6 | Bishop et al. [15] | 1992 | Prospective | Low quality | 1987–1988 | Not sppecified | 90 | 5 | 5.56 |
7 | Goldstein et al. [39] | 1993 | Prospective | Low quality | 1989–1991 | Alfa 1—Mentor | 112 | 3 | 2.68 |
8 | Choi et al. [40] | 1994 | Retrospective | Low quality | 1983–1993 | Variable | 295 | 3 | 1.02 |
9 | Fein et al. [41] | 1994 | Prospective | Low quality | 1988–1991 | GFS II—Mentor | 122 | 5 | 4.10 |
10 | Wilson and Delk [16] | 1995 | Prospective | Low quality | 1986–1993 | Inflatable reoperation | 428 | 43 | 10.05 |
Inflatable naive | 823 | 24 | 2.92 | ||||||
11 | Holloway and Farah [42] | 1997 | Prospective | Low quality | 1989–1994 | Inflatable | 145 | 3 | 2.07 |
12 | Anafarta et al. [43] | 1998 | Prospective | Low quality | 1989–1998 | AMS Dynaflex | 120 | 5 | 4.17 |
13 | Wilson et al. [10] | 1998 | Prospective | Low quality | 1994–1996 | Inflatable | 389 | 21 | 5.40 |
14 | Garber and Marcus[44] | 1998 | Prospective | Low quality | 7 years | Mentor A1 (3piece IPP) | 360 | 6 | 1.67 |
15 | Kabalin and Kessler [45] | 1998 | Prospective | Low quality | 1975–1980 | Scott; Small-carion | 145 | 5 | 3.45 |
16 | Montague et al. [46] | 2001 | Retrospective | Low quality | 1986–1999 | 3 piece inflatable; database | 491 | 10 | 2.04 |
17 | Cakan et al. [47] | 2003 | Retrospective | Low quality | 1993–2000 | Malleable 2 piece | 135 | 12 | 8.89 |
18 | Ferguson and Cespedes [48] | 2003 | Prospective | Low quality | 1992–1996 | Malleable | 94 | 1 | 1.06 |
19 | Carson [17] | 2004 | Database | Low quality | 2001–2003 | AMS 700 InhibiZone™ | 2261 | 15 | 0.66 |
AMS 700 no coating | 1944 | 32 | 1.65 | ||||||
20 | Wolter and Hellstrom [12] | 2004 | Database | Low quality | 2002–2003 | Titan coated | 2357 | 25 | 1.06 |
Alpha 1—no coating | 482 | 10 | 2.07 | ||||||
21 | Minervini et al. [49] | 2005 | Prospective | Low quality | 1975–2000 | Malleable—variable | 504 | 40 | 7.94 |
22 | Wilson et al. [23] | 2007 | Database | Low quality | 2001–2004 | AMS 700 InhibiZone™ naive | 306 | 1 | 0.33 |
AMS 700 InhibiZone™ reoperations | 161 | 8 | 4.97 | ||||||
23 | Kim et al. [50] | 2010 | Prospective | Low quality | 1991–2009 | AMS 700 | 397 | 8 | 2.02 |
24 | DiBlasio et al. [51] | 2010 | Retrospective | Low quality | 1997–2007 | Inflatable | 79 | 5 | 6.33 |
25 | Carson et al. [19] | 2011 | Database | Low quality | 2001–2008 | AMS 700 no coating | 3527 | 81 | 2.30 |
AMS 700 inhibiZone™ | 34,556 | 408 | 1.18 | ||||||
26 | Mulcahy and Carson [11] | 2011 | Database | Low quality | 2001–2008 | Inflatable coated | 35,737 | 394 | 1.10 |
Inflatable no coating | 3268 | 82 | 2.51 | ||||||
27 | Caire et al. [52] | 2011 | Retrospective | Low quality | 2005–2007 | Variable; reoperation | 105 | 7 | 6.67 |
28 | Dhabuwala et al. [20] | 2011 | Retrospective | Low quality | 2002–2010 | Titan; AMS InhibiZone™ | 497 | 10 | 2.01 |
29 | Chung et al. [14] | 2013 | Prospective | Low quality | 2006–2010 | AMS 700; Titan (both coated) | 138 | 3 | 2.17 |
30 | Eid et al. [26] | 2012 | Prospective | Low quality | 8.5y | AMS 700 InhibiZone™ | 704 | 14 | 1.99 |
AMS 700 InhibiZone™ + “no touch” | 1511 | 7 | 0.46 | ||||||
AMS no coating | 132 | 7 | 5.30 | ||||||
31 | Omarbasha et al. [53] | 2012 | Retrospective | Low quality | 2001–2011 | Variable no coating | 74 | 2 | 2.70 |
InhibiZone™ and Titan | 118 | 5 | 4.24 | ||||||
32 | Henry et al. [54] | 2012 | Prospective | Low quality | 2000–2007 | Variable reoperation | 214 | 12 | 5.61 |
33 | Henry et al. [55] | 2011 | Prospective | Low quality | 2000–2011 | Variable; salvage surgeries | 148 | 10 | 6.76 |
34 | Chung et al. [2] | 2012 | Prospective | Low quality | 1981–2010 | Variable | 955 | 14 | 1.47 |
35 | Cohen and Eid [56] | 2013 | Prospective | Low quality | 2003–2013 | Variable coated reoperation | 120 | 4 | 3.33 |
Reoperation and “no touch” | 283 | 1 | 0.35 | ||||||
36 | Pozza et al. [57] | 2015 | Prospective | Low quality | 1984–2013 | Variable | 500 | 15 | 3.00 |
37 | Mohamed et al. [29] | 2016 | Retrospective | Low quality | 2008–2015 | Malleable | 128 | 7 | 5.47 |
38 | Chiang et al. [7] | 2016 | Prospective | Low quality | 2004–2008 | Variable | 91 | 6 | 6.59 |
39 | Antonini et al. [58] | 2016 | Prospective | Low quality | 2011–2013 | AMS 700 e Titan both coated | 180 | 5 | 2.78 |
40 | Katz and Love [59] | 2017 | Prospective | Low quality | 2012–2015 | Inflatable coated + “no touch” | 150 | 1 | 0.67 |
41 | Sevinc et al. [60] | 2017 | Prospective | Low quality | 1998–2012 | Malleable and inflatable | 181 | 4 | 2.21 |